| Ruston James Sanchez, MD | |
|
6717 Perkins Rd, Baton Rouge, LA 70808-4263 | |
| (225) 572-5922 | |
| Not Available |
| Full Name | Ruston James Sanchez |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 10 Years |
| Location | 6717 Perkins Rd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043639495 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| Entity Name | Our Lady Of The Lake Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033494943 PECOS PAC ID: 4587849781 Enrollment ID: O20120529000377 |
News Archive
Pre-clinical research has generated some very promising findings about a prototype drug for the treatment of chronic lymphocytic leukemia.
Three forms of garlic - including raw garlic and two types of commercial garlic supplements - did not significantly reduce low-density lipoprotein (LDL or "bad") cholesterol during a six-month trial, according to results published in the February 26 issue of Archives of Internal Medicine.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
In a new study currently available on the bioRxiv* preprint server, a multinational group of researchers modeled an entire membrane-embedded spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and highlighted the potential of a specific mapping approach for unveiling cryptic, potentially druggable pockets on the viral surface.
› Verified 9 days ago
| Entity Name | Rjs Plastic Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174140594 PECOS PAC ID: 6800210550 Enrollment ID: O20200728001479 |
News Archive
Pre-clinical research has generated some very promising findings about a prototype drug for the treatment of chronic lymphocytic leukemia.
Three forms of garlic - including raw garlic and two types of commercial garlic supplements - did not significantly reduce low-density lipoprotein (LDL or "bad") cholesterol during a six-month trial, according to results published in the February 26 issue of Archives of Internal Medicine.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
In a new study currently available on the bioRxiv* preprint server, a multinational group of researchers modeled an entire membrane-embedded spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and highlighted the potential of a specific mapping approach for unveiling cryptic, potentially druggable pockets on the viral surface.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ruston James Sanchez, MD 1477 S Eugene St, Baton Rouge, LA 70808-1043 Ph: (225) 572-5922 | Ruston James Sanchez, MD 6717 Perkins Rd, Baton Rouge, LA 70808-4263 Ph: (225) 572-5922 |
News Archive
Pre-clinical research has generated some very promising findings about a prototype drug for the treatment of chronic lymphocytic leukemia.
Three forms of garlic - including raw garlic and two types of commercial garlic supplements - did not significantly reduce low-density lipoprotein (LDL or "bad") cholesterol during a six-month trial, according to results published in the February 26 issue of Archives of Internal Medicine.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
In a new study currently available on the bioRxiv* preprint server, a multinational group of researchers modeled an entire membrane-embedded spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and highlighted the potential of a specific mapping approach for unveiling cryptic, potentially druggable pockets on the viral surface.
› Verified 9 days ago
Erick Roy Sanchez, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 8777 Bluebonnet Blvd, Baton Rouge, LA 70810 Phone: 225-766-1899 | |
Dr. Gary Wayne Cox, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 8425 Cumberland Pl, Baton Rouge, LA 70806 Phone: 225-924-7514 Fax: 225-930-0987 | |
Mary C Ghere, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6717 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-412-4774 Fax: 225-953-8432 | |
Roy F Brabham Jr., M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3600 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-281-2669 Fax: 985-892-7070 | |
Dr. Jonathan Ernest Weiler, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 4212 Bluebonnet Blvd, Ste B, Baton Rouge, LA 70809 Phone: 225-399-0001 Fax: 225-399-0008 | |
Dr. Michael Stephen Hanemann Jr., M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5233 Dijon Dr, Baton Rouge, LA 70808 Phone: 225-766-2166 |